Dr. Naomi Sacks, Vice President, BlueRidge Life Sciences’ Pharmaceutical Commercialization division, is attending the annual meeting of ISPOR (The Professional Society for Health Economics and Outcomes Research), which is being held in Montreal, Canada, May 13–16, 2025. She is a co-author on a poster presentation, “Healthcare Resource Utilization for Medicare Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) and Exacerbations Coinfected with Pseudomonas aeruginosa.” If you are at ISPOR—or if you would like to learn more about BlueRidge Life Sciences’ Pharmaceutical Commercialization, and our rare disease expertise—reach out to Naomi and our team!
